Currently predicting for Thu, 2 May 2024

Trading levels for BMY

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 44.88 1.51 %
R2 44.59 0.87 %
R1 44.42 0.474 %
Current price: 44.21
Support S1 43.85 -0.81 %
S2 43.68 -1.20 %
S3 43.39 -1.85 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 51.59 16.69 %
R2 48.71 10.18 %
R1 44.70 1.11 %
Current price 44.21
Support S1 43.94 -0.611%
S2 0 .
S3 0 .

BMY Predictions History

2 years ago
AlexVel predicted that BMY for 2022-03-15 is going $69.41 (-0.49%)

2 years ago
JS predicted that BMY for 2021-06-08 is going $64.68 (1.54%)

2 years ago
saidgharibpour.242106 predicted that BMY for 2021-06-08 is going

Rank:

2 years ago
JS predicted that BMY for 2021-06-07 is going $65.10 (0.51%)

2 years ago
sunterzuber predicted that BMY for 2021-06-07 is going

Rank:

2 years ago
JS predicted that BMY for 2021-06-02 is going $64.97 (0.43%)

2 years ago
JS predicted that BMY for 2021-05-19 is going $65.43 (-0.18%)

2 years ago
sunterzuber predicted that BMY for 2021-05-19 is going

Rank:

2 years ago
sunterzuber predicted that BMY for 2021-05-18 is going

Rank:

2 years ago
JS predicted that BMY for 2021-05-17 is going $64.65 (-1.24%)

Click to get the best stock tips daily for free!

About Bristol-Myers Squibb Company

Bristol-Myers Squibb Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for th... BMY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT